Skip to content

Injection site tracker · WegovyWhere did you
inject today?

Keep your own record of the area and the day. It stays on this device.

1Medicine

Wegovy (semaglutide)Change

2Area

Choose your medicine above. The body appears here, with the areas its label names shaded.

Front
AbdomenThigh
Back
Back of upper arm
  • Area the label names
“Inject WEGOVY subcutaneously in the abdomen, thigh, or upper arm.”

Source 01 · Prescribing information · rev. 6/2026

3Record

Selected area

No area chosen

Choose an area on the body, or by name below.

Or choose by name · left and right are your own

Abdomen
Thigh
Back of upper arm

Your record

Nothing recorded yet.

Kept in this browser, on this device. We never receive your entries. On iPhone, Safari can clear a site’s saved data after seven days of using Safari without visiting that site. Adding this site to your Home Screen avoids that.

Calendar reminder, and clear my record

Calendar reminder

A repeating event for your own calendar. It does not name your medicine.

Start over

Deletes your record and settings from this browser.

What the label says about rotating

“Rotate injection sites with each dose.”
Source 01 · Prescribing information · rev. 6/2026
“You may inject in the same body area each week, but make sure it is not in the same spot each time.”
Source 02 · Instructions for Use, pen · rev. 6/2026
“lower stomach (keep 2 inches away from your belly button)”
Source 02 · Instructions for Use, pen · rev. 6/2026

Per-pen card · Wegovy (semaglutide)

What the Wegovy label says for your device

The label’s own words on the dose schedule, a missed dose and time out of the fridge. Open any line’s source to see where it comes from.

Your device, as the label names it

Strengths · Single-dose pen

“0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL, 2.4 mg/0.75 mL, or 7.2 mg/0.75 mL (WEGOVY HD) in a single-dose pen”
Source 01 · Prescribing information
Document
Prescribing information, for the Single-dose pen
Section
“DOSAGE FORMS AND STRENGTHS”
Label
Wegovy (semaglutide), revised 6/2026. How this label has changed
Read it on DailyMed

Dose schedule · every Wegovy device

“The recommended starting dosage of WEGOVY injection is 0.25 mg administered subcutaneously once weekly.”
Source 01 · Prescribing information
Document
Prescribing information
Section
section 2.2
Label
Wegovy (semaglutide), revised 6/2026. How this label has changed
Read it on DailyMed
“Table 1. Recommended Starting Dosage and Dosage Escalation of WEGOVY Injection for All Approved Indications in Adults and Pediatric Patients Aged 12 Years and Older”
WeeksOnce-weekly Subcutaneous Injection Dosage
1 through 40.25 mg
5 through 80.5 mg
9 through 121 mg
13 through 161.7 mg
17 and onwardSee the indication below for the recommended maintenance dosage(s)
Source 01 · Prescribing information
Document
Prescribing information
Section
section 2.2
Label
Wegovy (semaglutide), revised 6/2026. How this label has changed
Read it on DailyMed
“If patients do not tolerate a dose during dosage escalation, consider delaying dosage escalation for 4 weeks.”
Source 01 · Prescribing information
Document
Prescribing information
Section
section 2.2
Label
Wegovy (semaglutide), revised 6/2026. How this label has changed
Read it on DailyMed
“The maintenance dosage of WEGOVY injection for cardiovascular risk reduction in adults is either 2.4 mg (recommended) or 1.7 mg once weekly.”
Source 01 · Prescribing information
Document
Prescribing information
Section
section 2.2, “Cardiovascular Risk Reduction in Adults”
Label
Wegovy (semaglutide), revised 6/2026. How this label has changed
Read it on DailyMed
“The maintenance dosage of WEGOVY for weight reduction in adults is either 1.7 mg or 2.4 mg (recommended) injected subcutaneously once weekly.”
Source 01 · Prescribing information
Document
Prescribing information
Section
section 2.2, “Weight Reduction in Adults”
Label
Wegovy (semaglutide), revised 6/2026. How this label has changed
Read it on DailyMed
“For patients who tolerate the 2.4 mg dosage for at least 4 weeks and additional weight reduction is clinically indicated, the dosage may be increased to a maximum dosage of 7.2 mg subcutaneously once weekly.”
Source 01 · Prescribing information
Document
Prescribing information
Section
section 2.2, “Weight Reduction in Adults”
Label
Wegovy (semaglutide), revised 6/2026. How this label has changed
Read it on DailyMed
“The maintenance dosage of WEGOVY injection for weight reduction in pediatric patients aged 12 years and older is either 2.4 mg (recommended), or 1.7 mg once weekly.”
Source 01 · Prescribing information
Document
Prescribing information
Section
section 2.2, “Weight Reduction in Pediatric Patients Aged 12 Years and Older”
Label
Wegovy (semaglutide), revised 6/2026. How this label has changed
Read it on DailyMed
“The recommended maintenance dosage of WEGOVY injection for the treatment of noncirrhotic MASH with moderate to advanced liver fibrosis in adults is 2.4 mg injected subcutaneously once weekly.”
Source 01 · Prescribing information
Document
Prescribing information
Section
section 2.2, “Noncirrhotic MASH with Moderate to Advanced Liver Fibrosis in Adults”
Label
Wegovy (semaglutide), revised 6/2026. How this label has changed
Read it on DailyMed
“Use WEGOVY 1 time each week, on the same day each week, at any time of the day.”
Source 04 · Medication Guide
Document
Medication Guide
Section
“How should I use WEGOVY?”
Label
Wegovy (semaglutide), revised 6/2026. How this label has changed
Read it on DailyMed
“If you need to change the day of the week, you may do so as long as your last dose of WEGOVY was given 2 or more days before.”
Source 04 · Medication Guide
Document
Medication Guide
Section
“How should I use WEGOVY?”
Label
Wegovy (semaglutide), revised 6/2026. How this label has changed
Read it on DailyMed

Missed dose

“If you miss a dose of WEGOVY and the next scheduled dose is more than 2 days away (48 hours), take the missed dose as soon as possible. If you miss a dose of WEGOVY and the next scheduled dose is less than 2 days away (48 hours), do not administer the dose. Take your next dose on the regularly scheduled day.”
Source 04 · Medication Guide
Document
Medication Guide
Section
“How should I use WEGOVY?”
Label
Wegovy (semaglutide), revised 6/2026. How this label has changed
Read it on DailyMed
“If you miss doses of WEGOVY for 2 or more consecutive weeks, contact your healthcare provider to talk about how to restart your treatment.”
Source 04 · Medication Guide
Document
Medication Guide
Section
“How should I use WEGOVY?”
Label
Wegovy (semaglutide), revised 6/2026. How this label has changed
Read it on DailyMed

Day counter

Counts calendar days from today, or hours and minutes when a time is added, on this device. Nothing is saved or sent.

Out of the fridge · Single-dose pen

“If needed, before removing the pen or syringe cap, WEGOVY single-dose pen and single-dose syringe can be stored from 46°F to 86°F (8°C to 30°C) in the original carton for up to 28 days.”
Source 04 · Medication Guide
Document
Medication Guide, for the Single-dose pen and Single-dose syringe
Section
“How should I store WEGOVY?”
Label
Wegovy (semaglutide), revised 6/2026. How this label has changed
Read it on DailyMed
“Throw away the WEGOVY single-dose pen or syringe if it has been frozen, has been exposed to light or temperatures above 86°F (30°C), has been out of the refrigerator for 28 days or longer, or after use.”
Source 04 · Medication Guide
Document
Medication Guide, for the Single-dose pen and Single-dose syringe
Section
“How should I store WEGOVY?”
Label
Wegovy (semaglutide), revised 6/2026. How this label has changed
Read it on DailyMed

Wegovy label revised 6/2026; every line checked against it 10 Nov 2026. How these lines have changed. Quoted word for word from the label as published on DailyMed, the National Library of Medicine’s label database. DailyMed’s current label may differ from the most recent label at Drugs@FDA.

What the label says

The FDA label for Wegovy names the abdomen, the thigh and the upper arm, and says to change the injection site rather than reuse the same spot. Every line of the label about where to inject is below, quoted word for word, with a tracker set up for Wegovy.

This covers Wegovy injection. Wegovy tablets are a different product, taken by mouth, so they have no injection site. If you take Wegovy tablets, follow the tablet instructions in the Wegovy label and your prescriber. Wegovy label on DailyMed.

Every quote is checked word for word against the label on DailyMed; last checked November 10, 2026.

Source 01 · Prescribing information
Source 02 · Instructions for Use, pen
Source 03 · Instructions for Use, prefilled syringe
Source 04 · Medication Guide
Source 05 · Instructions for Use, WEGOVY HD
Source 06 · Instructions for Use, FlexTouch

The Wegovy label

Wegovy (semaglutide), Novo Nordisk. Label on DailyMed, revised 6/2026.

Every line of the Wegovy label about injecting

Where to inject

“Inject WEGOVY subcutaneously in the abdomen, thigh, or upper arm.”Source 01 · Prescribing information · rev. 6/2026
“You may inject into your upper leg (front of the thighs), lower stomach (keep 2 inches away from your belly button) or upper arm.”Source 02 · Instructions for Use, pen · rev. 6/2026

This label lists the sites above and does not say one is less painful than another.

The upper arm

“back of upper arm (only with help from someone else).”Source 03 · Instructions for Use, prefilled syringe · rev. 6/2026

The belly button

“lower stomach (keep 2 inches away from your belly button)”Source 02 · Instructions for Use, pen · rev. 6/2026

Changing the site

“Rotate injection sites with each dose.”Source 01 · Prescribing information · rev. 6/2026
“You may inject in the same body area each week, but make sure it is not in the same spot each time.”Source 02 · Instructions for Use, pen · rev. 6/2026

Skin to avoid

“Do not inject into an area where the skin is tender, bruised, red, or hard. Avoid injecting into areas with scars or stretch marks.”Source 02 · Instructions for Use, pen · rev. 6/2026

With insulin

The label does not address this.

How often

“Administer WEGOVY injection once weekly, on the same day each week, at any time of day, with or without meals.”Source 01 · Prescribing information · rev. 6/2026

Supply

Not on FDA’s drug shortage list (checked November 10, 2026).

Source: FDA Drug Shortages database, via openFDA. Do not rely on openFDA to make decisions regarding medical care; check with your pharmacy.

Label history

13 label versions since January 2024; 8 changed the wording this site quotes, most recently June 18, 2026. See every change.

Other GLP-1 medicines

Mounjaro and Zepbound · Ozempic · All eight labels compared